Reaction

Sinusitis Fungal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 778 reports · 44 co-occurring drugs

As of the last recalculation, Sinusitis Fungal appears in 778 FAERS reports alongside 44 co-occurring drug terms. The strongest observed disproportionality signal is PSYLLIUM HUSK (PRR 81.5).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Psyllium Husk	29	81.5	81.8
Micafungin Sodium	20	64.7	64.9
Nystatin Ointment	55	60.3	60.4
Nystatin Cream	55	60.2	60.3
Nystatin	56	59.0	59.1
Posaconazole Delayed-Release	23	57.7	57.8
Posaconazole	29	49.6	49.6
Docusate Sodium - Sennosides	54	48.1	48.2
Risedronate Sodium	50	45.9	46.0
Amphotericin B	20	43.8	43.9
Voriconazole Injection	34	43.8	43.8
Fluticasone Furoate And Vilanterol Trifenatate	53	42.2	42.3
Voriconazole	39	36.1	36.2
Pegaspargase	16	35.7	35.7
Itraconazole	15	35.0	35.1
Clarithromycin	41	33.7	33.7
Cytarabine	67	32.6	32.6
Vincristine Sulfate	33	31.4	31.5
Fluconazole	71	29.7	29.8
Estradiol Gel 0.1%	47	29.5	29.6
Estradiol Transdermal	47	29.5	29.6
Fluticasone Propionate Nasal	32	29.4	29.4
Zinc	25	28.0	28.0
Zinc Chloride	25	27.8	27.8
Docusate Sodium	55	27.4	27.4
Budesonide	56	27.3	27.3
Fludarabine Phosphate	38	27.1	27.2
Zinc Gluconate	25	26.4	26.4
Busulfan	15	26.0	26.0
Azacitidine For	16	24.0	24.0
Filgrastim	32	23.7	23.7
Montelukast	64	22.1	22.2
Azacitidine	22	20.4	20.4
Mercaptopurine	13	20.4	20.4
Cladribine	7	19.7	19.7
Mesna Injection	6	19.6	19.6
Mesna	6	19.2	19.2
Cefepime	10	18.9	18.9
Venetoclax	40	18.3	18.3
Estradiol	53	17.5	17.6
Mepolizumab	31	17.3	17.4
Cefepime Hydrochloride	10	16.8	16.8
Blinatumomab	4	10.3	10.3
Selinexor	3	9.3	9.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.